ALLMedicine™ Anaplastic Ganglioglioma Center
Research & Reviews 20 results
https://clinicaltrials.gov/ct2/show/NCT03919071
Mar 9th, 2023 - PRIMARY OBJECTIVE: I. To estimate the event-free survival (EFS) distribution for newly-diagnosed patients with BRAF^V600-mutant high-grade glioma (HGG) without H3 K27M mutations excluding anaplastic pleomorphic xanthoastrocytoma (aPXA) and anaplas...
https://doi.org/10.1111/nan.12847
Neuropathology and Applied Neurobiology; Reinhardt A, Pfister K et. al.
Aug 18th, 2022 - Anaplastic ganglioglioma is a rare tumour, and diagnosis has been based on histological criteria. The 5th edition of the World Health Organization Classification of Tumours of the Central Nervous System (CNS WHO) does not list anaplastic gangliogl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575428
AJNR. American Journal of Neuroradiology; Vaz A, Cavalcanti MS et. al.
May 6th, 2022 - Glioneuronal tumors are characterized exclusively by neurocytic elements (neuronal tumors) or a combination of neuronal and glial features (mixed neuronal-glial tumors). Most of these tumors occur in young patients and are related to epilepsy. Whi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629451
Neuro-oncology Rosenberg T, Yeo KK et. al.
Apr 10th, 2022 - The prognosis for patients with pediatric high-grade glioma (pHGG) is poor despite aggressive multimodal therapy. Objective responses to targeted therapy with BRAF inhibitors have been reported in some patients with recurrent BRAF-mutant pHGG but ...
https://doi.org/10.1007/s00381-022-05516-5
Child's Nervous System : ChNS : Official Journal of the I... Giglio MV, Matias LG et. al.
Apr 8th, 2022 - Anaplastic gangliogliomas (AGG) are rare tumors of the central nervous system (CNS) that commonly affect children and young adults, with an unusual infratentorial presentation, which is related to hydrocephalus and a worse prognosis. We report a c...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT03919071
Mar 9th, 2023 - PRIMARY OBJECTIVE: I. To estimate the event-free survival (EFS) distribution for newly-diagnosed patients with BRAF^V600-mutant high-grade glioma (HGG) without H3 K27M mutations excluding anaplastic pleomorphic xanthoastrocytoma (aPXA) and anaplas...
